DeLor names new marketing executives

DeLor Healthcare Communications named Teresa Leezer vice president of marketing. She will direct strategic marketing and communications efforts for existing clients and oversee new business development efforts. Leezer was executive director, oncology and virology marketing at Bristol-Meyers Squibb.
Teresa Flynn was named senior marketing manager. Flynn was a medical liaison and sales specialist for Abbott Laboratories.
Sharon Johnson was named business development manager for pharmaceutical product brands and Kristin Havill was also named business development manager for corporate pharmaceutical brands.
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.